Riskpilot← Back to searchSign inGet full accessNeuroCarrier Oy
OYDissolvedY-tunnus 3252505-5Purotie 1Computer programming activities · NACE 6210Est. 2021— employeeswww.evokailabs.com
Revenue 2024
EUR 0
EBITDA margin
—
Equity ratio
-112.2%
Financial strength
Net profit 2024
EUR -26K
| Revenue | EUR 0 | — |
| EBITDA | EUR -25K | — |
| Net profit | EUR -26K | — |
| Total assets | EUR 41K | — |
| Equity | EUR -46K | — |
| Employees | — | — |
Legal name
NeuroCarrier Oy
Y-tunnus number
3252505-5
Legal form
Osakeyhtiö
NACE code
6210 · Computer programming activities
Founded
3. joulukuuta 2021
Share capital
EUR 0
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Ohjelmistojen suunnittelu ja valmistus,
lääketieteellinen tutkimus ja kehittäminen sekä
kaikki muu laillinen liiketoiminta.
Address
Purotie 1
Phone
+3580505579155
Email
alejandro.antalich@evokailabs.com
Website
www.evokailabs.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 10 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 |
| EBITDA | 3 | 0 | −25 |
| Depreciation & amort. | −0 | −0 | −0 |
| EBIT | 3 | 0 | −26 |
| Net financials | — | 0 | −0 |
| Profit before tax | 3 | 0 | −26 |
| Tax | 1 | −0 | −0 |
| Net profit | 2 | 0 | −26 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 3 | 0 | 41 |
| Equity | 2 | 0 | −46 |
| Long-term debt | — | 0 | 60 |
| Short-term debt | 1 | 0 | 26 |
| Total debt | 1 | 0 | 86 |
EBITDA margin
-2542900.0%
This company
15.8%
Market median
-16094404% vs market
20222024
Equity ratio
-112.2%
This company
38.2%
Market median
-394% vs market
20222024
Return on equity
-2587000.0%
This company
18.4%
Market median
-14059883% vs market
20222024
Net profit margin
-2587000.0%
This company
8.1%
Market median
-31938372% vs market
20222024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20222024
Debt / equity
1.89×
This company
0.62×
Market median
-205% vs market
20222024
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
JP Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2021 – 2023 |
JM Chief Executive Officer | Chief Executive Officer | 2021 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2023 | |
| Chairperson | 2023 | |
| Board of Directors | 2023 | |
| Former (1) | ||
| Chairperson | 2021 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NeuroCarrier Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Janne Petteri Mäkelä | Deputy Chief Executive Officer | 0 companies |
| Jarmo Mikael Majapuro | Chief Executive Officer | 0 companies |
| Paola Alexandra Díaz | Board of Directors | 0 companies |
| Eero Petteri Joenpolvi | Chairperson | 0 companies |
| Alejandro Carlos Antalich Raibar | Chairperson | 0 companies |
| Juan Martin Presa Lombardi | Board of Directors | 0 companies |